课题基金 / 基金详情

项目摘要

项目成果

Robert SCOTT LOKEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The discovery of bioactive small molecules has emerged as a major theme in academic research and is central to the NIH Roadmap initiative. Using modest equipment and a unique collection of natural and synthetic compounds, we have established a vibrant small molecule screening program at UCSC that has yielded fruitful results. Our current screening throughput, however, is far too slow to keep pace with our expanding compound collection. The Crews lab's natural product collection has grown substantially with the recent implementation of new high-throughput purification techniques, and the acquisition of commercial and private compound libraries will bring our total in-house collection to more than 50,000 by the end of this year. Our current screening lab consists of a manual compound transfer device and low throughput liquid handling equipment capable of performing operations on one plate at a time. This proposal is to request high-throughput screening (HTS) equipment for the establishment of a state-of-the-art screening facility at UCSC. Based on the screens proposed, this facility will lead to the identification of novel small molecule probes of the following biological processes: cell cycle checkpoints, cell growth, RNA splicing, transcription elongation, chromatin remodeling, inflammation (due to lipoxygenase activity), actin dynamics, bacterial biofilm formation, malaria infection, and cytokinesis. The creation of a modern HTS facility at UCSC will thus facilitate the discovery of potential therapeutic leads and drug targets related to a variety of disease states. Relevance: High throughput screening is expected to have a major impact in small molecule probe discovery in the public sector just as it has played a role in speeding up drug lead discovery in industry. In order to bring this goal to fruition, integrated HTS equipment must be available to researchers for the validation and implementation of screens in high throughput format.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/acs.jcim.9b00217
发表时间: 2019-06-24
期刊: Journal of chemical information and modeling
影响因子: 5.6
作者: [Ono S, Naylor MR, Townsend CE, Okumura C, Okada O, Lokey RS]
通讯作者: Lokey RS
A Strategy for Direct Chemical Activation of the Retinoblastoma Protein.
视网膜母细胞瘤蛋白的直接化学激活策略。
DOI: 10.1021/acschembio.6b00011
发表时间: 2016
期刊: ACS chemical biology
影响因子: 4
作者: [Pye,CameronR, Bray,WalterM, Brown,EliseR, Burke,JasonR, Lokey,RScott, Rubin,SethM]
通讯作者: Rubin,SethM
DOI: 10.1016/j.chembiol.2012.12.007
发表时间: 2013-02-21
期刊: Chemistry & biology
影响因子: --
作者: [Schulze CJ, Bray WM, Woerhmann MH, Stuart J, Lokey RS, Linington RG]
通讯作者: Linington RG
Large-scale cytological profiling for functional analysis of bioactive compounds.
用于生物活性化合物功能分析的大规模细胞学分析。
DOI: 10.1039/c3mb70245f
发表时间: 2013
期刊: Molecular bioSystems
影响因子: --
作者: [Woehrmann,MarcosH, Bray,WalterM, Durbin,JamesK, Nisam,SeanC, Michael,AliciaK, Glassey,Emerson, Stuart,JoshuaM, Lokey,RScott]
通讯作者: Lokey,RScott
9
    Advancing the basic science of membrane permeability in macrocyclic peptides
    Upgrade of core imaging instrumentation and robotics for the UCSC Chemical Screening Center
    Cyclic peptide permeability
    Cyclic peptide permeability
    国内基金
    海外基金
    Handbook of the Mathematics of the Arts and Sciences的中文翻译
    • 批准号:
      12226504
    • 项目类别:
      数学天元基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2022
    • 负责人:
      黄朝凌
    • 依托单位:
    ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
    • 批准号:
      --
    • 项目类别:
      --
    • 资助金额:
      35万元
    • 批准年份:
      2020
    • 负责人:
      陈加祥
    • 依托单位:
    ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
    • 批准号:
      82060278
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      35.0万元
    • 批准年份:
      2020
    • 负责人:
      陈加祥
    • 依托单位:
    促进肿瘤凋亡的融合蛋白CPP-TRAIL-ARTS C27的制备及机制研究
    • 批准号:
      81372444
    • 项目类别:
      面上项目
    • 资助金额:
      70.0万元
    • 批准年份:
      2013
    • 负责人:
      易成
    • 依托单位: